Get emailed when ROIV changes direction
Insider selling: $763,129,052 sold by 14 insiders (30d)
Factor divergence:
DIVERGENCE: analyst_revisions, options_sentiment bullish vs estimate_revisions bearish
Est. revisions:
-11.1%
(3 up, 0 down in 30d)
Factor Model (net +0.3)
Factor Model
net +0.3 2.0 / 10
Est. Revisions
-0.6
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0
Roivant Gains $2.25B Settlement, Boosts Cash
Watch: Focus on Q3 2026 FDA rulings on Brepocitinib for potential approval and catalyst-driven stock moves.
Roivant Sciences won a $2.25 billion global settlement with Moderna in March 2026, raising cash to over $4.5 billion with zero debt. Its Phase 3 trial for Brepocitinib showed a 21.6-point patient improvement and the FDA granted Priority Review targeting Q3 2026. The company also completed a $1 billion share repurchase, retiring about 15% of shares.
This cash boost and regulatory progress mitigate prior concerns from heavy insider selling and institutional exits, potentially stabilizing the share price and validating the pipeline's value.
Evidence
2h ago
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman
yahoo-finance
12d ago
Piper Sandler main ROIV: Overweight → Overweight
15d ago
Insider sell by GLINE MATTHEW (ROIV): $23,382,600
15d ago
Insider sell by GOLD DANIEL ALLEN (ROIV): $51,820,727
15d ago
Insider sell by SUKHATME MAYUKH (ROIV): $10,641,739
15d ago
Insider sell by RAMASWAMY VIVEK (ROIV): $10,129,810
15d ago
Insider sell by VENKER ERIC (ROIV): $11,154,942
15d ago
Insider sell by RAMASWAMY VIVEK (ROIV): $13,084,796
7 older signals
15d ago
Insider sell by RAMASWAMY VIVEK (ROIV): $22,456,210
15d ago
Insider buy by GLINE MATTHEW (ROIV): $49,957
15d ago
Insider sell by VENKER ERIC (ROIV): $25,524,777
15d ago
Insider sell by VENKER ERIC (ROIV): $10,781,813
15d ago
Insider sell by VENKER ERIC (ROIV): $14,467,502
15d ago
Insider sell by RAMASWAMY VIVEK (ROIV): $37,939,112
15d ago
Insider sell by MANCHESTER KEITH S (ROIV): $26,304,500
Fundamentals & Data ▾
Roivant Sciences Ltd.
Healthcare · Biotechnology
Mkt Cap
$20B
Beta
1.21
52w Range
$10.58 - $30.33
Short Interest
24.5M 4.52%
Days to Cover
4.8 +5%
Technicals
downtrend
from 52w Hi
-6.9%
1w return
-5.2%
Insiders
selling
0B / 5S
Analysts
mixed
EPS Estimate
$-0.35
-11.1% 30d
3up / 0dn
Est. Dispersion
66%
3 analysts
Analyst Target
$36
$29 - $41
Options P/C
9.26
Insider Cluster
strong sell
1B / 7S (officer)
Fund Convergence
strong
Elliott, Citadel, Soros
Financials
Revenue
$2M -78% YoY
FCF
$-192M
Gross Margin
65%
Op Margin
-16966%
Momentum:
accelerating
Top Holders
Elliott
$140M
Citadel
$64M
Soros
Recent Filings & Data
insider trade
136
net selling
· $763,129,052 sold
· $49,957 bought
14 insiders · 136 transactions (30d)
Recent transactions
PULIK RICHARD · award
SUKHATME MAYUKH · other
GLINE MATTHEW · other
FITZGERALD MEGHAN · sell · $1,921,500
FITZGERALD MEGHAN · exercise · $616,000
VENKER ERIC · sell · $5,648,000
SUKHATME MAYUKH · sell · $619,528
VENKER ERIC · exercise · $770,000
EPPERLY MELISSA B · sell · $1,200,573
TORTI FRANK M · sell · $82,039,460
TORTI FRANK M · exercise · $11,550,000
VENKER ERIC · sell · $5,298,000
VENKER ERIC · exercise · $770,000
GOLD DANIEL ALLEN · sell · $32,658,518
MANCHESTER KEITH S · sell · $32,658,518
SUKHATME MAYUKH · sell · $8,985,003
SUKHATME MAYUKH · exercise · $8,261,755
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
VENKER ERIC · sell · $4,384,000
VENKER ERIC · exercise · $770,000
SUKHATME MAYUKH · sell · $28,902,500
SUKHATME MAYUKH · exercise · $40,553,620
TORTI FRANK M · other
VENKER ERIC · sell · $6,179,750
VENKER ERIC · exercise · $1,662,003
TORTI FRANK M · award · $3,937,281
PULIK RICHARD · sell · $9,122,307
PULIK RICHARD · exercise · $1,001,000
GOLD DANIEL ALLEN · sell · $39,065,213
SUKHATME MAYUKH · exercise · $754,625
MANCHESTER KEITH S · sell · $39,065,213
RAMASWAMY VIVEK · sell · $67,942,352
RAMASWAMY VIVEK · exercise · $93,513,326
GLINE MATTHEW · sell · $37,723,200
GLINE MATTHEW · exercise · $47,062,049
VENKER ERIC · sell · $4,170,000
GOLD DANIEL ALLEN · sell · $26,304,500
MANCHESTER KEITH S · sell · $26,304,500
RAMASWAMY VIVEK · sell · $37,939,112
VENKER ERIC · sell · $4,044,000
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
VENKER ERIC · sell · $14,467,502
VENKER ERIC · exercise · $13,494,421
VENKER ERIC · sell · $10,781,813
VENKER ERIC · exercise · $5,956,032
VENKER ERIC · sell · $25,524,777
VENKER ERIC · exercise · $6,015,140
GLINE MATTHEW · buy · $49,957
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
GOLD DANIEL ALLEN · award
MANCHESTER KEITH S · award
FITZGERALD MEGHAN · award
RAMASWAMY VIVEK · sell · $22,456,210
VENKER ERIC · sell · $1,172,000
VENKER ERIC · exercise · $385,000
TORTI FRANK M · award
VENKER ERIC · award
VENKER ERIC · sell · $1,152,000
VENKER ERIC · exercise · $385,000
MOMTAZEE JAMES C · award
EPPERLY MELISSA B · award
RAMASWAMY VIVEK · sell · $13,084,796
VENKER ERIC · sell · $1,145,000
RAMASWAMY VIVEK · sell · $8,454,808
VENKER ERIC · sell · $11,154,942
VENKER ERIC · exercise · $5,332,350
VENKER ERIC · sell · $1,095,000
RAMASWAMY VIVEK · sell · $10,129,810
VENKER ERIC · sell · $1,022,000
PULIK RICHARD · award
MOMTAZEE JAMES C · award
OREN ILAN · award
OREN ILAN · award
EPPERLY MELISSA B · award
VENKER ERIC · sell · $8,190,725
VENKER ERIC · exercise · $3,858,897
HUMES JENNIFER · award
VENKER ERIC · sell · $1,065,000
VENKER ERIC · sell · $4,561,041
VENKER ERIC · exercise · $2,310,000
KUMAR RAKHI · sell · $2,372,825
KUMAR RAKHI · exercise · $721,875
MOMTAZEE JAMES C · award
RAMASWAMY VIVEK · other
OREN ILAN · award
EPPERLY MELISSA B · award
VENKER ERIC · sell · $1,128,000
VENKER ERIC · sell · $4,141,662
VENKER ERIC · exercise · $1,925,000
SUKHATME MAYUKH · sell · $10,641,739
SUKHATME MAYUKH · exercise · $3,412,012
VENKER ERIC · sell · $1,149,000
SUKHATME MAYUKH · sell · $4,971,637
SUKHATME MAYUKH · exercise · $1,588,448
VENKER ERIC · sell · $1,132,000
MOMTAZEE JAMES C · award
OREN ILAN · award
VENKER ERIC · sell · $1,165,000
EPPERLY MELISSA B · award
GOLD DANIEL ALLEN · sell · $51,820,727
MANCHESTER KEITH S · sell · $5,866,308
KUMAR RAKHI · sell · $2,972,500
KUMAR RAKHI · exercise · $962,500
GLINE MATTHEW · sell · $23,382,600
GLINE MATTHEW · exercise · $5,967,500
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
GOLD DANIEL ALLEN · award
MANCHESTER KEITH S · award
FITZGERALD MEGHAN · award
VENKER ERIC · award
SUKHATME MAYUKH · award
GLINE MATTHEW · award
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
FITZGERALD MEGHAN · award
KUMAR RAKHI · award
PULIK RICHARD · award
HUMES JENNIFER · sell · $384,073
GLINE MATTHEW · sell · $8,449,810
MOMTAZEE JAMES C · award
OREN ILAN · award
EPPERLY MELISSA B · award
VENKER ERIC · sell · $5,918,000
HUMES JENNIFER · award
15 signals · latest 2h ago
Get alerted when ROIV changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.